When consumers can understand just bit more about what biotech is, how it works, and how it relates to them personally, they’re supportive of GMO, according to Jennifer Armen, vice president at Okanagan Specialty Fruits.
Despite pervasive consumer disapproval, scientists and seed companies have far from abandoned GMOs as a subject of research and development and some new approaches using GM technology could address the more pervasive consumer concerns.
iBio uses highly automated indoor farming methods to manufacture pharmaceutical drugs and, according to Barry Holtz, president, it already has much of the technology that today’s food-growing indoor farms are just starting to develop.
Bayer, through Condon, has indicated that it is aware the merger presents an opportunity to reset public opinion about controversial technologies like GMOs and Dicamba, but the executive announcement last week suggests a complete overhaul is not in the cards.
“I think CRISPR and other gene editing tools mark a real turning point in the conversation,” Sam Kass, partner at Acre Venture Partners and former senior policy advisor for nutrition in the White House, told the audience of the Food Loves Tech.